Found: 6
Select item for more details and to access through your institution.
Candidate Gene Study of <i>TRAIL</i> and <i>TRAIL Receptors</i>: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062540
- By:
- Publication type:
- Article
TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021766
- By:
- Publication type:
- Article
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
- Published in:
- BMC Neurology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2377-13-82
- By:
- Publication type:
- Article
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Bioética emergente.
- Published in:
- Kranion, 2021, v. 16, n. 1, p. 30
- By:
- Publication type:
- Article
Neuropalliative care in times of war.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 10, p. 3130, doi. 10.1111/ene.15383
- By:
- Publication type:
- Article